ImmuCell Announces Financial Results for the First Half of 2008

PORTLAND, ME, August 4 / MARKET WIRE/ -- ImmuCell Corporation (NASDAQ: ICCC) today announced the results of its operations for the three and six month periods "In this very challenging economic environment, we are gratified that our customers have rewarded us with an 8% increase in sales our lead product, First Defense?, during the six-month period ended June 30, 2008," commented Michael F. Brigham, President and CEO. "First Defense? sales continue to be seasonal with lower sales expected during the second and third quarters." Product development expenses increased by 44%, or $130,000, to $423,000 during the three-month period ended June 30, 2008 in comparison to the same period in 2007. Product development expenses increased by 35%, or $195,000, to $755,000 during the six-month period ended June 30, 2008 in comparison to the... [read full story]